187 related articles for article (PubMed ID: 26175146)
1. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.
Razzak Chaudhary S; Workeneh BT; Montez-Rath ME; Zolopa AR; Klotman PE; Winkelmayer WC
Nephrol Dial Transplant; 2015 Oct; 30(10):1734-40. PubMed ID: 26175146
[TBL] [Abstract][Full Text] [Related]
2. HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study.
Abbott KC; Trespalacios FC; Agodoa LY; Ahuja TS
BMC Nephrol; 2003 Jul; 4():5. PubMed ID: 12837135
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.
Abbott KC; Hypolite I; Welch PG; Agodoa LY
J Nephrol; 2001; 14(5):377-83. PubMed ID: 11730270
[TBL] [Abstract][Full Text] [Related]
4. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
[TBL] [Abstract][Full Text] [Related]
5. Predictors of renal outcome in HIV-associated nephropathy.
Post FA; Campbell LJ; Hamzah L; Collins L; Jones R; Siwani R; Johnson L; Fisher M; Holt SG; Bhagani S; Frankel AH; Wilkins E; Ainsworth JG; Larbalestier N; Macallan DC; Banerjee D; Baily G; Thuraisingham RC; Donohoe P; Hendry BM; Hilton RM; Edwards SG; Hangartner R; Howie AJ; Connolly JO; Easterbrook PJ
Clin Infect Dis; 2008 Apr; 46(8):1282-9. PubMed ID: 18444868
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated nephropathy and end-stage renal disease in children in the United States.
Ahuja TS; Abbott KC; Pack L; Kuo YF
Pediatr Nephrol; 2004 Jul; 19(7):808-11. PubMed ID: 15141343
[TBL] [Abstract][Full Text] [Related]
7. End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years.
Bickel M; Marben W; Betz C; Khaykin P; Stephan C; Gute P; Haberl A; Knecht G; Wolf T; Brodt HR; Geiger H; Herrmann E; Jung O
HIV Med; 2013 Mar; 14(3):127-35. PubMed ID: 22994610
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-associated nephropathy.
Lai CF; Huang JW; Lin WC; Hung CC; Chu TS
J Formos Med Assoc; 2006 Aug; 105(8):680-4. PubMed ID: 16935771
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy and treatment options for HIV-associated nephropathy.
Menez S; Hanouneh M; McMahon BA; Fine DM; Atta MG
Expert Opin Pharmacother; 2018 Jan; 19(1):39-48. PubMed ID: 29224373
[TBL] [Abstract][Full Text] [Related]
10. Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy?
Ahuja TS; Collinge N; Grady J; Khan S
Am J Kidney Dis; 2003 May; 41(5):1060-4. PubMed ID: 12722041
[TBL] [Abstract][Full Text] [Related]
11. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition.
Wei A; Burns GC; Williams BA; Mohammed NB; Visintainer P; Sivak SL
Kidney Int; 2003 Oct; 64(4):1462-71. PubMed ID: 12969167
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study.
Lucas GM; Eustace JA; Sozio S; Mentari EK; Appiah KA; Moore RD
AIDS; 2004 Feb; 18(3):541-6. PubMed ID: 15090808
[TBL] [Abstract][Full Text] [Related]
13. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy.
Winston JA; Burns GC; Klotman PE
Semin Nephrol; 1998 Jul; 18(4):373-7. PubMed ID: 9692350
[TBL] [Abstract][Full Text] [Related]
14. HIV-associated nephropathy: an urban epidemic.
Monahan M; Tanji N; Klotman PE
Semin Nephrol; 2001 Jul; 21(4):394-402. PubMed ID: 11455528
[TBL] [Abstract][Full Text] [Related]
15. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.
Freedman BI; Soucie JM; Stone SM; Pegram S
Am J Kidney Dis; 1999 Aug; 34(2):254-8. PubMed ID: 10430971
[TBL] [Abstract][Full Text] [Related]
16. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
[TBL] [Abstract][Full Text] [Related]
17. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.
Foy MC; Estrella MM; Lucas GM; Tahir F; Fine DM; Moore RD; Atta MG
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1524-32. PubMed ID: 23685946
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of rationing dialysis therapy in biopsy-proven end-stage renal disease in South Africa.
Okpechi IG; Swanepoel CR; Rayner BL
J Nephrol; 2012; 25(4):551-7. PubMed ID: 21956769
[TBL] [Abstract][Full Text] [Related]
19. Temporal Trends in Incident Mortality in Dialysis Patients: Focus on Sex and Racial Disparities.
Shah S; Leonard AC; Meganathan K; Christianson AL; Thakar CV
Am J Nephrol; 2019; 49(3):241-253. PubMed ID: 30820004
[TBL] [Abstract][Full Text] [Related]
20. Effect of highly active antiretroviral therapy on renal failure in human immunodeficiency virus-associated nephropathy.
Takahashi T; Nakamura T; Kanda T; Iwamoto A
Res Commun Mol Pathol Pharmacol; 2004; 115-116():151-6. PubMed ID: 17564314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
